Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jarlier

Showing results (61-70 of 171) with videos related to

Pageof 18
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 14, 2011
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011S Vaux, A Carbonne, J M Thiolet, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Antibiotic susceptibility pattern of Mycobacterium marinumA Aubry, V Jarlier, S Escolano, et al.
Pathologie-Biologie|June 1, 1984
[Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983]R Bismuth, V Jarlier, M H Nicolas, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2010
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosisF Brossier, N Veziris, C Truffot-Pernot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 25, 2009
Superficial community-acquired skin infections: prevalence of bacteria and antibiotic susceptibility in FranceG Lorette, Ph Beaulieu, F A Allaert, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in miceN Veziris, N Lounis, A Chauffour, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|October 23, 2004
[Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections]N Veziris, A Aubry, W Sougakoff, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2008
Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infectionsA R Larsen, R L Skov, V Jarlier, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1989
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporinsV Jarlier, M H Nicolas, A Philippon, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacaeM H Nicolas, N Honore, V Jarlier, et al.
Pageof 18

Showing results (61-70 of 171) with videos related to

Sort By:
Pageof 18
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 14, 2011
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011S Vaux, A Carbonne, J M Thiolet, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Antibiotic susceptibility pattern of Mycobacterium marinumA Aubry, V Jarlier, S Escolano, et al.
Pathologie-Biologie|June 1, 1984
[Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983]R Bismuth, V Jarlier, M H Nicolas, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2010
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosisF Brossier, N Veziris, C Truffot-Pernot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 25, 2009
Superficial community-acquired skin infections: prevalence of bacteria and antibiotic susceptibility in FranceG Lorette, Ph Beaulieu, F A Allaert, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in miceN Veziris, N Lounis, A Chauffour, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|October 23, 2004
[Utility of molecular tools in diagnosis, treatment, and epidemiology of mycobacterial infections]N Veziris, A Aubry, W Sougakoff, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2008
Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infectionsA R Larsen, R L Skov, V Jarlier, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1989
In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporinsV Jarlier, M H Nicolas, A Philippon, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Molecular genetic analysis of cephalosporinase production and its role in beta-lactam resistance in clinical isolates of Enterobacter cloacaeM H Nicolas, N Honore, V Jarlier, et al.
Pageof 18